Table 4.
Study goal | Author (year)a | Sample sizeb | Patient status | Contrast | Finding |
---|---|---|---|---|---|
Illness progression | Woods (2005) | 982 | FES and Chronic | HC vs. SZ | WB volume reduced |
Steen (2006) | 1424 | FES | HC vs. FES | WB volume reduced and ventricular volume is increased | |
Ellison-Wright (2008) | 1556 | FES and Chronic | HC vs. SZ | Bilateral reductions in caudate GM present in FES but not chronic SZ | |
Glahn (2008) | 1195 | FES and Chronic | HC vs. SZ | Increased GM density in striatal regions | |
Fornito (2009) | 1646 | FES and Chronic | HC vs. SZ | Reduced GM volume and concentration in frontal, temporal, thalamic and striatal regions | |
Bora (2011) | 1999 | Chronic and FES | HC vs. SZ | Chronic illness associated with more severe GM abnormalities | |
Chan (2011) | 466 | FES | HC vs. FES | Lower GM volume | |
808 | Chronic | Chronic vs. FES | More extensive GM volume reductions than FES group | ||
Olabi (2011) | 928 | Chronic and FES | HC vs. SZ | SZ show significantly greater reductions in WB volume and WB GM volume over time | |
De Peri (2012) | 45 studies | FES | FES vs. HC | Significant overall reduction in WB total GM | |
Haijma (2012) | 8327 | Chronic and FES | HC vs. SZ | Larger GM reductions were associated with longer duration of illness | |
Vita (2012) | 813 | Chronic and FES | HC vs. SZ | FES have more significant pattern of progressive loss of WB GM volume than Chronic SZ. GM volume modulated by percentage of patients taking atypical APDs | |
Medication exposure | Navari (2009) | 33 Studies | NN and NT | NT vs. HC or NN | Antipsychotics, specifically typical, cause increased volume of structures within the basal ganglia in the NT group |
8327 | Medicated | HC vs. medicated | Total brain volume of grey matter structures were significantly decreased | ||
Leung (2011) | 162 | NN-FES | HC vs. NN-FES | SZ showed GM deficits in subcortical regions including the striatum | |
336 | NT-FES | NN-FES vs. NT-FES | NT SZ showed GM deficits in caudate, cingulate, and inferior TL | ||
Haijma (2013) | 771 | NN | NN vs. HC and NT | NN had more pronounced volume reductions in the caudate nucleus and thalamus than HC or NT | |
Ebdrup (2013) | 13 studies | Medicated | Baseline vs. after medication | No studies found that specific FGAs induce basal ganglia volume increases. SGA therapy associated with volumetric increases and decreases in basal ganglia. |
Abbreviations: APD, antipsychotic; FES, first episode schizophrenia; FGA, first generation antipsychotic; GM, grey matter; HC, healthy controls; NN, neuroleptic naïve; NT, neuroleptic treated; SGA, second generation antipsychotic; STG, superior temporal gyrus; SZ, schizophrenia; TL, temporal lobe; WB, whole brain;
Articles are listed in the references section
Some of the articles only reported their total number of studies and not sample size.